Critical Marketing Considerations for Medical Technologies
How do marketing messages affect third-party payers?
Tag Archives: payers
Transition to ICD-10: Potential Challenges & Benefits for U.S. Payers
Payer organizations face a host of issues in the conversion to ICD-10.
The Best Value Proposition. Ever.
Identify the roadmap through which you’re evolving with the changing healthcare landscape.
Engaging ACOs: A How-To for Life Science Companies
Successful accountable care organizations consist of a superior confluence of quality efforts, physician engagement, patient engagement, the right administration and the ability to keep costs down. The challenge comes in balancing these efforts while keeping costs to a minimum.
A Major National Health Plan Medical Director Shares Insights on How Coverage Decisions are Made
This Q&A session, with an active Regional Medical Director involved in traditional health plan policy and payment development, as well as emerging value-based models, reveals important information and attitudes toward coverage of new/existing technologies and standards of evidence.
This Q&A session, with an active Regional Medical Director involved in traditional health plan policy and payment development, as well as emerging value-based models, reveals important information and attitudes toward coverage of new/existing technologies and standards of evidence.
The Appeals Process
Presenting clinical evidence to payers is the most efficient method of gaining coverage. But when this strategy is unsuccessful or hits a wall, a ground-up approach is required, relying on consistent and steady support from local physician champions that demonstrates broad acceptance of a technology.
Presenting clinical evidence to payers is the most efficient method of gaining coverage. But when this strategy is unsuccessful or hits a wall, a ground-up approach is required, relying on consistent and steady support from local physician champions that demonstrates broad acceptance of a technology.
Minimally Invasive Procedures
Ever since the advent of laparoscopic surgery some 25 years ago, payers have become wary of minimally invasive surgery. What should device manufacturers do?
Ever since the advent of laparoscopic surgery some 25 years ago, payers have become wary of minimally invasive surgery. What should device manufacturers do?
